TARS
Tarsus Pharmaceuticals Inc
78.60$
+2.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | -63.2% | 6.6% | -189.9% | -673.4% | -45.4% | -2.8% | |
| – | – | 0.3% | 0.5% | 1.3% | 5.0% | 0.7% | 0.4% | |
| – | – | 2.5% | 14.8% | 52.1% | 113.7% | 15.2% | 9.2% | |
| – | – | 11.9% | 26.3% | 54.1% | – | – | – | |
| – | – | 4.4% | 2.4% | -3.7% | 1.8% | 2.1% | 3.2% | |
| – | – | 1.4% | 1.0% | 2.0% | 31.5% | 0.9% | 2.2% | |
| – | – | -1.4% | -1.0% | -560.2% | 805.9% | -108.9% | -9.3% | |
| – | – | -0.1% | 0.6% | 290.3% | – | – | – | |
| – | – | 59.8% | 35.1% | -3.4% | 57.3% | 41.0% | 0.0% | |
| – | – | 394.1% | 0.0% | 364.1% | 746.1% | 84.5% | 31.8% | |
| – | – | 329.6% | 5.6% | -386.1% | 878.6% | -69.7% | 19.7% | |
| – | – | -64.6% | 5.5% | -191.9% | -705.0% | -46.2% | -4.9% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.